The FAT10- and ubiquitin-dependent degradation machineries exhibit common and distinct requirements for MHC class I antigen presentation

Cellular and Molecular Life Sciences

Volumn 69, Issue 14, 2012, Pages 2443-2454

  Ebstein, Frédéric ^a   Lehmann, Andrea ^a   Kloetzel, Peter Michael ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Antigen presentation; FAT10; Immunoproteasomes; NUB1; PA28; Ubiquitin

Indexed keywords

CYTOMEGALOVIRUS ANTIGEN PP65; EPITOPE; HLA A2 ANTIGEN; HLA ANTIGEN; HLA F ADJACENT TRANSCRIPT 10 ANTIGEN; HYBRID PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UBIQUITIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIGEN PRESENTATION; ARTICLE; CELLULAR DISTRIBUTION; CONJUGATION; CONTROLLED STUDY; CROSS PRESENTATION; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; STEADY STATE; UBIQUITINATION; UPREGULATION;

ANTIGEN PRESENTATION; CYTOMEGALOVIRUS; HEK293 CELLS; HELA CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-A2 ANTIGEN; HUMANS; MUSCLE PROTEINS; PHOSPHOPROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEASOME INHIBITORS; PROTEOLYSIS; RNA INTERFERENCE; RNA, SMALL INTERFERING; UBIQUITIN; UBIQUITINS; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 5;

EID: 84864337803     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-012-0933-5     Document Type: Article

References (40)

1. Townsend A, Bastin J, Gould K, Brownlee G, Andrew M, Coupar B, Boyle D, Chan S, Smith G (1988) Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J Exp Med 168(4):1211-1224
2. Grant EP, Michalek MT, Goldberg AL, Rock KL (1995) Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation. J Immunol 155(8):3750-3758
3. Tobery TW, Siliciano RF (1997) Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization. J Exp Med 185(5):909-920 (Pubitemid 27119875)
4. Goldberg AL, Cascio P, Saric T, Rock KL (2002) The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides. Mol Immunol 39(3-4):147-164 (Pubitemid 35013508)
5. Tanaka K, Kasahara M (1998) The MHC class I ligand-generating system: roles of immunoproteasomes and the interferongamma-inducible proteasome activator PA28. Immunol Rev 163:161-176 (Pubitemid 28327869)
6. Fruh K, Yang Y (1999) Antigen presentation by MHC class I and its regulation by interferon gamma. Curr Opin Immunol 11(1): 76-81 (Pubitemid 29082341)
7. Chen W, Norbury CC, Cho Y, Yewdell JW, Bennink JR (2001) Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens. J Exp Med 193(11):1319-1326 (Pubitemid 32524782)
8. Gileadi U, Moins-Teisserenc HT, Correa I, Booth BL Jr, Dunbar PR, Sewell AK, Trowsdale J, Phillips RE, Cerundolo V (1999) Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein. J Immunol 163(11):6045-6052
9. Cerundolo V, Kelly A, Elliott T, Trowsdale J, Townsend A (1995) Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport. Eur J Immunol 25(2):554-562
10. Schwarz K, Eggers M, Soza A, Koszinowski UH, Kloetzel PM, Groettrup M (2000) The proteasome regulator PA28alpha/beta can enhance antigen presentation without affecting 20S proteasome subunit composition. Eur J Immunol 30(12):3672-3679 (Pubitemid 32005241)
11. Kruger E, Kuckelkorn U, Sijts A, Kloetzel PM (2003) The components of the proteasome system and their role in MHC class I antigen processing. Rev Physiol Biochem Pharmacol 148:81-104
12. Kerscher O, Felberbaum R, Hochstrasser M (2006) Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu Rev Cell Dev Biol 22:159-180
13. Herrmann J, Lerman LO, Lerman A (2007) Ubiquitin and ubiquitin- like proteins in protein regulation. Circ Res 100(9):1276-1291 (Pubitemid 46742918)
14. Ebstein F, Lange N, Urban S, Seifert U, Kruger E, Kloetzel PM (2009) Maturation of human dendritic cells is accompanied by functional remodelling of the ubiquitin-proteasome system. Int J Biochem Cell Biol 41(5):1205-1215
15. Raasi S, Schmidtke G, Groettrup M (2001) The ubiquitin-like protein FAT10 forms covalent conjugates and induces apoptosis. J Biol Chem 276(38):35334-35343
16. Ross MJ, Wosnitzer MS, Ross MD, Granelli B, Gusella GL, Husain M, Kaufman L, Vasievich M, D'Agati VD, Wilson PD, Klotman ME, Klotman PE (2006) Role of ubiquitin-like protein FAT10 in epithelial apoptosis in renal disease. J Am Soc Nephrol 17(4):996-1004
17. Lee CG, Ren J, Cheong IS, Ban KH, Ooi LL, Yong Tan S, Kan A, Nuchprayoon I, Jin R, Lee KH, Choti M, Lee LA (2003) Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers. Oncogene 22(17):2592-2603 (Pubitemid 36605607)
18. Ji F, Jin X, Jiao CH, Xu QW, Wang ZW, Chen YL (2009) FAT10 level in human gastric cancer and its relation with mutant p53 level, lymph node metastasis and TNM staging. World J Gastroenterol 15(18):2228-2233
19. Canaan A, Yu X, Booth CJ, Lian J, Lazar I, Gamfi SL, Castille K, Kohya N, Nakayama Y, Liu YC, Eynon E, Flavell R, WeissmanSM (2006) FAT10/diubiquitin- like protein-deficient mice exhibit minimal phenotypic differences. Mol Cell Biol 26(13):5180-5189 (Pubitemid 43955829)
20. Chiu YH, Sun Q, Chen ZJ (2007) E1-L2 activates both ubiquitin and FAT10. Mol Cell 27(6):1014-1023 (Pubitemid 47488190)
21. Aichem A, Pelzer C, Lukasiak S, Kalveram B, Sheppard PW, Rani N, Schmidtke G, Groettrup M (2010) USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis. Nat Commun 1:13
22. Hipp MS, Kalveram B, Raasi S, Groettrup M, Schmidtke G (2005) FAT10, a ubiquitin-independent signal for proteasomal degradation. Mol Cell Biol 25(9):3483-3491 (Pubitemid 40559557)
23. Kuckelkorn U, Ferreira EA, Drung I, Liewer U, Kloetzel PM, Theobald M (2002) The effect of the interferon-gamma-inducible processing machinery on the generation of a naturally tumorassociated human cytotoxic T lymphocyte epitope within a wildtype and mutant p53 sequence context. Eur J Immunol 32(5):1368-1375 (Pubitemid 34546264)
24. Seifert U, Bialy LP, Ebstein F, Bech-Otschir D, Voigt A, Schroter F, Prozorovski T, Lange N, Steffen J, Rieger M, Kuckelkorn U, Aktas O, Kloetzel PM, Kruger E (2010) Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell 142(4):613-624
25. Deveraux Q, Ustrell V, Pickart C, Rechsteiner M (1994) A 26 S protease subunit that binds ubiquitin conjugates. J Biol Chem 269(10):7059-7061 (Pubitemid 24217884)
26. Thrower JS, Hoffman L, Rechsteiner M, Pickart CM (2000) Recognition of the polyubiquitin proteolytic signal. EMBO J 19(1):94-102 (Pubitemid 30009229)
27. Schultz ES, Chapiro J, Lurquin C, Claverol S, Burlet-Schiltz O, Warnier G, Russo V, Morel S, Levy F, Boon T, Van den Eynde BJ, van der Bruggen P (2002) The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome. J Exp Med 195(4):391-399 (Pubitemid 34461293)
28. Sun Y, Sijts AJ, Song M, Janek K, Nussbaum AK, Kral S, Schirle M, Stevanovic S, Paschen A, Schild H, Kloetzel PM, Schadendorf D (2002) Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells. Cancer Res 62(10):2875-2882 (Pubitemid 34525774)
29. Schmidtke G, Kalveram B, Weber E, Bochtler P, Lukasiak S, Hipp MS, Groettrup M (2006) The UBA domains of NUB1L are required for binding but not for accelerated degradation of the ubiquitin-like modifier FAT10. J Biol Chem 281(29):20045-20054 (Pubitemid 44065779)
30. Hipp MS, Raasi S, Groettrup M, Schmidtke G (2004) NEDD8 ultimate buster-1L interacts with the ubiquitin-like protein FAT10 and accelerates its degradation. J Biol Chem 279(16):16503-16510 (Pubitemid 38509349)
31. Bachem A, Guttler S, Hartung E, Ebstein F, Schaefer M, Tannert A, Salama A, Movassaghi K, Opitz C, Mages HW, Henn V, Kloetzel PM, Gurka S, Kroczek RA (2010) Superior antigen cross-presentation and XCR1 expression define human CD11c + CD141 + cells as homologues of mouse CD8+ dendritic cells. J Exp Med 207(6):1273-1281
32. Buchsbaum S, Bercovich B, Ciechanover A (2012) FAT10 is a proteasomal degradation signal that is itself regulated by ubiquitination. Mol Biol Cell 23(1):225-232
33. Norbury CC, Basta S, Donohue KB, Tscharke DC, Princiotta MF, Berglund P, Gibbs J, Bennink JR, Yewdell JW (2004) CD8 +T cell cross-priming via transfer of proteasome substrates. Science 304(5675):1318-1321 (Pubitemid 38697427)
34. Wolkers MC, Brouwenstijn N, Bakker AH, Toebes M, Schumacher TN (2004) Antigen bias in T cell cross-priming. Science 304(5675):1314-1317 (Pubitemid 38697426)
35. Basta S, Stoessel R, Basler M, van den Broek M, Groettrup M (2005) Cross-presentation of the long-lived lymphocytic choriomeningitis virus nucleoprotein does not require neosynthesis and is enhanced via heat shock proteins. J Immunol 175(2):796-805 (Pubitemid 41094961)
36. Blachere NE, Darnell RB, Albert ML (2005) Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation. PLoS Biol 3(6):e185
37. Janda J, Schoneberger P, Skoberne M, Messerle M, Russmann H, Geginat G (2004) Cross-presentation of Listeria-derived CD8 T cell epitopes requires unstable bacterial translation products. J Immunol 173(9):5644-5651 (Pubitemid 39392152)
38. Shen L, Sigal LJ, Boes M, Rock KL (2004) Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. Immunity 21(2):155-165 (Pubitemid 39094046)
39. Seifert U, Kruger E (2008) Remodelling of the ubiquitin-proteasome system in response to interferons. Biochem Soc Trans 36(Pt 5):879-884
40. Sugiura T (2011) The cellular level of TRIM31, an RBCC protein overexpressed in gastric cancer, is regulated by multiple mechanisms including the ubiquitin-proteasome system. Cell Biol Int 35(7):657-661